Juergen Froehlich
Hoofd Techniek/Wetenschap/O&O bij ARCTURUS THERAPEUTICS HOLDINGS INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Juergen Froehlich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| APPILI THERAPEUTICS INC. | Directeur/Bestuurslid | 27-01-2020 | - |
| Independent Dir/Board Member | 27-01-2020 | - | |
| SPEXIS AG | Hoofd Techniek/Wetenschap/O&O | 30-12-2021 | - |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
| Verkoop & Marketing | 01-03-2023 | - |
Loopbaan van Juergen Froehlich
Eerdere bekende functies van Juergen Froehlich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Verkoop & Marketing | 01-01-2022 | 01-04-2023 |
| ARADIGM CORPORATION | Hoofd Techniek/Wetenschap/O&O | 31-05-2018 | 14-02-2019 |
| ARADIGM CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-11-2013 | 11-02-2018 |
| Algemeen Adviseur | 01-11-2013 | 11-02-2018 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Algemeen Adviseur | 01-10-2011 | 01-09-2013 |
Opleiding van Juergen Froehlich
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
| State University of New York at Albany | Masters Business Admin |
| Graduate School of Business Administration Zürich | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Zwitserland | 3 |
| Duitsland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| General Counsel | 2 |
| Masters Business Admin | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| APPILI THERAPEUTICS INC. | Health Technology |
| SPEXIS AG | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
- Beurs
- Insiders
- Juergen Froehlich
- Ervaring
